United States · FDA National Drug Code directory
Pregabalin
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 71610-930_3ab511fe-2be7-d9fd-e063-6394a90ad973
- Product NDC
- 71610-930
- Form
- CAPSULE
- Composition / generic term
- Pregabalin
- Labeler
- Aphena Pharma Solutions - Tennessee, LLC
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20210824
- Source listing expiry
- 20261231
Source-listed ingredients
- PREGABALIN — 50 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 30 CAPSULE in 1 BOTTLE (71610-930-30) · 71610-930-30
- 56 CAPSULE in 1 BOTTLE (71610-930-46) · 71610-930-46
- 60 CAPSULE in 1 BOTTLE (71610-930-53) · 71610-930-53
- 84 CAPSULE in 1 BOTTLE (71610-930-54) · 71610-930-54
- 90 CAPSULE in 1 BOTTLE (71610-930-60) · 71610-930-60
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →